Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cardiovascular Diabetology
JournalCitation impact & published research
Cardiovascular Diabetology is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 4,091 works, 186,762 citations, an h-index of 168 and an APC (USD) of 3,690.
4,091
Works
186,762
Citations
168
h-index
3,690
APC (USD)
IDs:OpenAlex
What are the most-cited papers on Cardiovascular Diabetology?
ScholarIQmost cited works
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
Chenguang Li, Jie Zhang, Mei Xue, Xiaoyu Li, Fei Han, Xiangyang Liu, Linxin Xu, Yunhong Lu, Ying Cheng, Ting Li, Xiaochen Yu, Bei Sun, Liming Chen
Cardiovascular Diabetology. 2019597 CitationsOPEN ACCESS
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou, Ronnie Har, Nora Fagan, Odd Erik Johansen, Hans‐Juergen Woerle, Maximilian von Eynatten, Uli C. Broedl
Cardiovascular Diabetology. 2014471 CitationsOPEN ACCESS
Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care
Alessandra da Silva, Ana Paula Silva Caldas, Helen Hermana Miranda Hermsdorff, Ângela Cristine Bersch-Ferreira, Camila Ragne Torreglosa, Bernardete Weber, Josefina Bressan
Cardiovascular Diabetology. 2019353 CitationsOPEN ACCESS
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
Qingmiao Shao, Lei Meng, Sharen Lee, Gary Tse, Mengqi Gong, Zhiwei Zhang, Jichao Zhao, Yungang Zhao, Guangping Li, Tong Liu
Cardiovascular Diabetology. 2019295 CitationsOPEN ACCESS
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
Keiichi Torimoto, Yosuke Okada, Hiroko Mori, Yoshiya Tanaka
Cardiovascular Diabetology. 2013285 CitationsOPEN ACCESS
Related on ScholarIQ
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
Paper
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
Paper
Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care
Paper
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
Paper
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
Paper
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Paper